Side-by-side comparison of AI visibility scores, market position, and capabilities
Global #1 OTC ibuprofen brand owned by Haleon (LSE/NYSE: HLN, GSK 2022 spinoff); Pfizer exited $3B+ stake early 2025 with ADA Seal for Advil Dual Action dental pain competing with Tylenol and Aleve for OTC analgesic market.
Advil is a global over-the-counter ibuprofen pain relief brand — owned by Haleon plc (LSE: HLN / NYSE: HLN), the consumer healthcare company spun off from GSK on July 18, 2022, with Pfizer completing its full stake exit in early 2025 for $3+ billion — providing consumers with 23+ ibuprofen-based product varieties for pain, headache, cold, and sleep management including Advil Extra Strength, Advil Rapid Release Gels, Advil PM, Advil Dual Action (ibuprofen + acetaminophen), and Children's Advil. Advil entered the US market in 1984 (the first OTC ibuprofen in America, considered the "most famous prescription-to-OTC switch in history") and generates approximately $800 million+ annually as one of Haleon's flagship brands alongside Sensodyne, Panadol, Centrum, and Theraflu. In September 2024, Advil Dual Action became the first OTC pain reliever to earn the American Dental Association (ADA) Seal of Acceptance for temporary management of acute dental pain.
Solv Health is a same-day appointment booking platform for urgent care, primary care, and telehealth, offering patients transparent wait times and insurance-aware scheduling.
Solv Health operates a consumer-facing booking platform that aggregates same-day availability from urgent care centers, primary care practices, and telehealth providers — giving patients the ability to find and book immediate care without calling multiple clinics or waiting in walk-in lines. The platform displays real-time wait times, insurance acceptance, and directions, making the experience of finding immediate care as simple as booking a restaurant reservation.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.